Review
Published on 12 Jun 2023
Transcription factor genetics and biology in predisposition to bone marrow failure and hematological malignancy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1183318
- 3,166 views
- 3 citations
Type at least 3 characters
1,747 articles
Articles
Review
Published on 09 Jun 2023
Myeloproliferative neoplasms – blurring the lines between cancer and chronic inflammatory disorder
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1208089
- 6,906 views
- 2 citations
Original Research
Published on 09 Jun 2023
Dyslipidemia in diffuse large B-cell lymphoma based on the genetic subtypes: a single-center study of 259 Chinese patients
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1172623
- 1,831 views
- 2 citations
Editorial
Published on 09 Jun 2023
Editorial: Real-world data and real-world evidence in hematologic malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1232980
- 1,215 views
Case Report
Published on 08 Jun 2023
Case Report: Effects of multiple myeloma therapy on essential thrombocythemia and vice versa: a case of synchronous dual hematological malignancy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1213942
- 2,149 views
- 2 citations
Original Research
Published on 08 Jun 2023
Development and validation of platelet-to-albumin ratio as a clinical predictor for diffuse large B-cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1138284
- 1,832 views
- 4 citations
Original Research
Published on 08 Jun 2023
Immune cell proportions correlate with clinicogenomic features and ex vivo drug responses in acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1192829
- 1,603 views
- 1 citation
Case Report
Published on 07 Jun 2023
Case Report: Avelumab and ruxolitinib to manage polycythemia vera and secondary metastatic Merkel cell carcinoma: a possible successful combination
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1212638
- 1,501 views
Correction
Published on 06 Jun 2023
Corrigendum: Interpreting flow cytometry with caution: a case report of follicular lymphoma in leukemic phase misdiagnosed as chronic lymphocytic leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1229649
- 782 views
Original Research
Published on 05 Jun 2023
Phenotyping of lymphoproliferative tumours generated in xenografts of non-small cell lung cancer
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1156743
- 3,294 views
- 5 citations
Original Research
Published on 05 Jun 2023
Identification of aberrantly expressed lncRNAs and ceRNA networks in multiple myeloma: a combined high-throughput sequencing and microarray analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1160342
- 1,831 views
- 2 citations
Original Research
Published on 02 Jun 2023
Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1176698
- 4,449 views
- 4 citations
Original Research
Published on 31 May 2023
Validity of Italian administrative healthcare data in describing the real-world utilization of infusive antineoplastic drugs: the study case of rituximab use in patients treated at the University Hospital of Siena for onco-haematological indications
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1059109
- 1,404 views
- 1 citation
Brief Research Report
Published on 29 May 2023
The pro-tumorigenic cytokine IL-32 has a high turnover in multiple myeloma cells due to proteolysis regulated by oxygen-sensing cysteine dioxygenase and deubiquitinating enzymes
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1197542
- 2,265 views
- 2 citations
Case Report
Published on 25 May 2023
TFG::ALK fusion in ALK positive large B-cell lymphoma: a case report and review of literature
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1174606
- 2,530 views
- 1 citation
Original Research
Published on 25 May 2023
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1208741
- 1,883 views
- 2 citations